✦ LIBER ✦

Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system

✍ Scribed by Michael Adler; Filip De Pauw; Pierre Vereerstraeten; Agnese Fancello; Jan Lerut; Peter Starkel; Hans Van Vlierberghe; Roberto Troisi; Vincent Donckier; Olivier Detry; Jean Delwaide; Peter Michielsen; Thierry Chapelle; Jacques Pirenne; Frederik Nevens

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 155 KB
Volume: 14
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21399

No coin nor oath required. For personal study only.

✦ Synopsis

Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation, the rules governing priority and access to the waiting list are not well defined. Patient-and tumor-related variables were evaluated in 226 patients listed primarily for HCC in Belgium, a region where the allocation system is patient-driven, priority being given to sicker patients, based on the Child-Turcotte-Pugh (CTP) score. Intention-to-treat and posttransplantation survival rates at 4 years were 56.5 and 66%, respectively, and overall HCC recurrence rate was 10%. The most significant predictors of failure to receive a transplant in due time were baseline CTP score equal to or above 9 (relative risk [RR] 4.1; confidence interval [CI]: 1.7-9.9) and ␣ fetoprotein above 100 ng/mL (RR 3.0; CI: 1.2-7.1). Independent predictors of posttransplantation mortality were age equal to or above 50 years (RR 2.5; CI: 1.0-3.7) and United Network for Organ Sharing pathological tumor nodule metastasis above the Milan criteria (RR 2.1; CI: 1.0-5.9). Predictors of recurrence (10%) were ␣ fetoprotein above 100 ng/mL (RR 3.2; CI:1.1-10) and vascular involvement of the tumor on the explant (RR 3.6; CI: 1.1-11.3). Assessing the value of the pretransplantation staging by imaging compared to explant pathology revealed 34% accuracy, absence of carcinoma in 8.3%, overstaging in 36.2%, and understaging in 10.4%. Allocation rules for HCC should consider not only tumor characteristics but also the degree of liver impairment. Patients older than 50 years with a stage above the Milan criteria at transplantation have a poorer prognosis after transplantation.

📜 SIMILAR VOLUMES

Drop-out rates of patients with hepatoce

Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization

✍ Yamini K. Maddala; Linda Stadheim; James C. Andrews; Lawrence J. Burgart; Charle 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Patients with hepatocellular carcinoma (HCC) are assigned model for end stage liver disease (MELD) scores to provide access to liver transplantation (LT). An equitable policy would equate HCC progression beyond acceptable transplantation criteria with death on the waiting list. However, limited info

Tools for monitoring patients with hepat

Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation

✍ Norman Kneteman; Tito Livraghi; David Madoff; Eduardo de Santibañez; Michael Kew 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

For patients who are initially being listed for liver transplantation and for patients who are seeking to retain their active status on the wait list, the first step in the diagnostic consideration of hepatocellular carcinoma (HCC) is the accurate identification and staging of the tumors. Advances i

A new priority policy for patients with

A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system

✍ Fabio Piscaglia; Valeria Camaggi; Matteo Ravaioli; Gian Luca Grazi; Matteo Zanel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation under the model for end-stage liver disease (MELD) allocation system is still being debated. We analyzed the impact of a MELD adjustment for HCC, which consisted of the addition of an extra scor

Expanded criteria for liver transplantat

Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the International Registry of Hepatic Tumors in Liver Transplantation

✍ Nicholas Onaca; Gary L. Davis; Robert M. Goldstein; Linda W. Jennings; Göran B. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 2 views

Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging

Resection prior to liver transplantation

Resection prior to liver transplantation for hepatocellular carcinoma: A strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function

✍ Ronnie T. Poon; Sheung Tat Fan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

Objective: To evaluate the feasibility and postoperative course of liver transplantation (LT) in cirrhotic patients who underwent liver resection prior to LT for HCC. Summary Background Data: Although LT provides longer survival than liver resection for treatment of small HCCs, donor shortage and lo

Criteria for diagnosing benign portal ve

Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation

✍ Fabio Piscaglia; Alice Gianstefani; Matteo Ravaioli; Rita Golfieri; Alberta Capp 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 1 views